Regulation of Chloride Channels by Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor-Induced α-Defensin 5
Biological and Pharmaceutical Bulletin · 2024
DOI: 10.1248/bpb.b23-00672 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biological and Pharmaceutical Bulletin, 2024. Verfasst von Ippei Uemura und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacy, Graduate School of Pharmaceutical Sciences, Hokkaido University of Science. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, alpha-Defensins. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 38 Literaturangaben.
Abstract (Originalsprache)
Epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) are used to treat non-small cell lung cancer with EGFR mutations. However, first-generation erlotinib and second-generation afatinib often cause diarrhea, which may develop because of the association between EGFR-TKIs and the chloride channel or abnormalities in the intestinal microbiota due to disruption of the intestinal immune system. As reports on the effects of EGFR-TKIs on intestinal immunity are lacking, we aimed to determine whether the intestinal immune system is involved in the molecular effects of EGFR-TKIs on chloride channels using Caco-2 cells. Initially, we evaluated the association of chloride channels with α-defensin 5 (DEFA5), a marker of intestinal immunity. Erlotinib and afatinib significantly increased the extracellularly secreted DEFA5 level and autophagy-related 16-like 1 and X-box binding protein 1 transcript levels, indicative of enhanced granule exocytosis. Conversely, intracellular DEFA5 and Toll-like receptor 4 protein expression and tumor necrosis factor-α transcript levels decreased significantly, suggesting that Toll-like receptor 4 suppression repressed DEFA5 production. Furthermore, among the chloride channels, DEFA5 was found to significantly increase the transcript levels of cystic fibrosis transmembrane conductance regulators. These results indicate that DEFA5 plays a significant role in the mechanism of chloride channel-mediated diarrhea induced by EGFR-TKIs. Therefore, we successfully elucidated the potential host action of DEFA5 in cancer therapy for the first time.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Pharmacy, Graduate School of Pharmaceutical Sciences, Hokkaido University of Science.
- Department of Pharmaceutics, Faculty of Pharmaceutical Sciences, Hokkaido University of Science.
- Laboratory of Clinical Pharmaceutics & Therapeutics, Faculty of Pharmaceutical Sciences, Hokkaido University.
- Education Research Center for Clinical Pharmacy, Faculty of Pharmaceutical Sciences, Hokkaido University.
Zitieren
APA
Uemura, I., Takahashi-Suzuki, N., Kita, F., Kobayashi, M., Yamada, T., Iseki, K., & Satoh, T. (2024). Regulation of Chloride Channels by Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor-Induced α-Defensin 5. Biological and Pharmaceutical Bulletin. https://doi.org/10.1248/bpb.b23-00672
Vancouver
Uemura I, Takahashi-Suzuki N, Kita F, Kobayashi M, Yamada T, Iseki K, et al. Regulation of Chloride Channels by Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor-Induced α-Defensin 5. Biological and Pharmaceutical Bulletin. 2024. doi:10.1248/bpb.b23-00672
BibTeX
@article{Uemura2024,
author = {Uemura, Ippei and Takahashi-Suzuki, Natsuko and Kita, Fumiya and Kobayashi, Masaki and Yamada, Takehiro and Iseki, Ken and Satoh, Takashi},
title = {Regulation of Chloride Channels by Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor-Induced α-Defensin 5},
journal = {Biological and Pharmaceutical Bulletin},
year = {2024},
doi = {10.1248/bpb.b23-00672}
}
EUVIMED